BGNE - BeiGene, Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.86B
Enterprise Value 37.56B
Trailing P/E N/A
Forward P/E 1-10.94
PEG Ratio (5 yr expected) 1-0.48
Price/Sales (ttm)20.41
Price/Book (mrq)5.67
Enterprise Value/Revenue 317.43
Enterprise Value/EBITDA 6-11.15

Trading Information

Stock Price History

Beta (3Y Monthly) 1.31
52-Week Change 3-13.19%
S&P500 52-Week Change 31.52%
52 Week High 3182.30
52 Week Low 3105.19
50-Day Moving Average 3132.19
200-Day Moving Average 3130.56

Share Statistics

Avg Vol (3 month) 3256.87k
Avg Vol (10 day) 3277.43k
Shares Outstanding 560.1M
Float 37.42M
% Held by Insiders 10.03%
% Held by Institutions 188.60%
Shares Short (Jul 31, 2019) 43.65M
Short Ratio (Jul 31, 2019) 417.04
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 46.04%
Shares Short (prior month Jun 28, 2019) 44.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -153.32%
Operating Margin (ttm)-159.31%

Management Effectiveness

Return on Assets (ttm)-22.72%
Return on Equity (ttm)-47.55%

Income Statement

Revenue (ttm)434.05M
Revenue Per Share (ttm)7.36
Quarterly Revenue Growth (yoy)360.80%
Gross Profit (ttm)-509.49M
EBITDA -678.58M
Net Income Avi to Common (ttm)-665.5M
Diluted EPS (ttm)-11.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.54B
Total Cash Per Share (mrq)25.49
Total Debt (mrq)275.38M
Total Debt/Equity (mrq)17.53
Current Ratio (mrq)6.46
Book Value Per Share (mrq)25.76

Cash Flow Statement

Operating Cash Flow (ttm)-544.16M
Levered Free Cash Flow (ttm)-512.1M